Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1

Table 2

Effects of myricetin on blood glucose, heart weight (HW), body weight (BW), and lung weight (LW). Data were presented as means ± SEM; , compared with CON or M group, and ^#, compared with STZ group.

	CON	M	STZ	STZ + M
n	12	12	16	16
Blood glucose (mM)	6.3 ± 1.23	6.5 ± 1.47	27.1 ± 2.33^∗	25.3 ± 3.45^#
BW (g)	30.64 ± 1.90	29.74 ± 1.41	21.95 ± 2.34^∗	26.56 ± 2.41^#
HW (mg)	135 ± 5.31	129.4 ± 3.52	109.46 ± 3.30^∗	120.07 ± 2.62^#
LW (mg)	148.25 ± 6.70	151.4 ± 8.73	144.4 ± 8.68	148.6 ± 12.21
HW/BW	4.40 ± 0.31	4.35 ± 0.18	4.99 ± 0.34	4.53 ± 0.27
LW/BW	4.84 ± 0.33	4.98 ± 0.43	6.60 ± 0.64^∗	5.61 ± 0.41^#